1-2 of 2
Bingshan Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Search Study：XPO1 Inhibitor (ATG-010) Monotherapy in Heavily Pretreated Chinese Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Yuqin Song, Qingqing Cai, Qingyuan Zhang, Xiuhua Sun, Haiyan Yang, Zhihua Yao, Liqun Zou, Liling Zhang, Junning Cao, Tingyu Wang, Lanfang Li, Yao Liu, Hongmei Jing, Sujun Gao, Kaiyang Ding, Bingshan Liu, Jun Zhao, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6234.
https://doi.org/10.1182/blood-2023-180413
Published: 2023
Journal Articles

Low MDR1 and BAALC expression Identifies a New Subgroup of Adult Cytogenetically Normal Acute Myeloid Leukemia with a Favorable Outcome

Xutao Guo, M.D., Feili Chen, M.D., Pengcheng Shi, M.D., Jie Zha, M.D., Bingshan Liu, M.D., Haiqing Zheng, Bing Xu, M.D. PhD
Journal: Blood
Blood (2012) 120 (21): 4312.
https://doi.org/10.1182/blood.V120.21.4312.4312
Published: 2012